Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Biosimilars
May 16, 2023
Study Explores Cost Effectiveness of Trastuzumab Biosimilars
May 16, 2023
Comparing Monoclonal Antibody Biosimilars With Marketed Biologics
May 16, 2023
Investigating Biosimilar Use in Oncology From 2019 to 2021
June 16, 2022
Introduction to Two Recently Approved Insulin Glargine Biosimilars
June 8, 2022
What Are the Barriers to Biosimilar Use in Oncology?
March 15, 2022
Anticipating the First Adalimumab Biosimilar
October 14, 2020
Trials for Biosimilars Found to Be as Rigorous as for Reference Products
June 18, 2019
Biosimilars: Not Simply Generics
Load More
X
May 2023
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image